ID PPM1L_HUMAN Reviewed; 360 AA. AC Q5SGD2; Q2M3J2; Q96NM7; DT 10-JAN-2006, integrated into UniProtKB/Swiss-Prot. DT 21-DEC-2004, sequence version 1. DT 27-MAR-2024, entry version 152. DE RecName: Full=Protein phosphatase 1L; DE EC=3.1.3.16; DE AltName: Full=Protein phosphatase 1-like; DE AltName: Full=Protein phosphatase 2C isoform epsilon; DE Short=PP2C-epsilon; GN Name=PPM1L; Synonyms=PP2CE; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY. RC TISSUE=Fetal brain; RX PubMed=15560375; DOI=10.1023/b:mole.0000043624.96006.eb; RA Jin F., Ji C., Liu L., Dai J., Gu S., Sun X., Xie Y., Mao Y.; RT "Molecular cloning and characterization of a novel human protein RT phosphatase 2C cDNA (PP2C epsilon)."; RL Mol. Biol. Rep. 31:197-202(2004). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC TISSUE=Brain; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4). RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP FUNCTION, AND INTERACTION WITH MAP3K5. RX PubMed=17456047; DOI=10.1042/bj20070231; RA Saito J., Toriumi S., Awano K., Ichijo H., Sasaki K., Kobayashi T., RA Tamura S.; RT "Regulation of apoptosis signal-regulating kinase 1 by protein phosphatase RT 2Cepsilon."; RL Biochem. J. 405:591-596(2007). CC -!- FUNCTION: Acts as a suppressor of the SAPK signaling pathways by CC associating with and dephosphorylating MAP3K7/TAK1 and MAP3K5, and by CC attenuating the association between MAP3K7/TAK1 and MAP2K4 or MAP2K6. CC {ECO:0000269|PubMed:17456047}. CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + O-phospho-L-seryl-[protein] = L-seryl-[protein] + CC phosphate; Xref=Rhea:RHEA:20629, Rhea:RHEA-COMP:9863, Rhea:RHEA- CC COMP:11604, ChEBI:CHEBI:15377, ChEBI:CHEBI:29999, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:83421; EC=3.1.3.16; CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + O-phospho-L-threonyl-[protein] = L-threonyl-[protein] + CC phosphate; Xref=Rhea:RHEA:47004, Rhea:RHEA-COMP:11060, Rhea:RHEA- CC COMP:11605, ChEBI:CHEBI:15377, ChEBI:CHEBI:30013, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:61977; EC=3.1.3.16; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250}; CC Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250}; CC Note=Binds 2 magnesium or manganese ions per subunit. {ECO:0000250}; CC -!- SUBUNIT: Interacts with MAP3K7/TAK1 (By similarity). Interacts with CC MAP3K5. {ECO:0000250, ECO:0000269|PubMed:17456047}. CC -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I CC membrane protein {ECO:0000305}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=4; CC Name=1; CC IsoId=Q5SGD2-1; Sequence=Displayed; CC Name=2; CC IsoId=Q5SGD2-2; Sequence=VSP_016927; CC Name=3; CC IsoId=Q5SGD2-3; Sequence=VSP_037552, VSP_037553; CC Name=4; CC IsoId=Q5SGD2-4; Sequence=VSP_037554, VSP_037555; CC -!- TISSUE SPECIFICITY: Ubiquitous. Highly expressed in heart, placenta, CC lung, liver, kidney and pancreas. {ECO:0000269|PubMed:15560375}. CC -!- SIMILARITY: Belongs to the PP2C family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AY337264; AAR00269.1; -; mRNA. DR EMBL; AK055115; BAB70856.1; -; mRNA. DR EMBL; BC104885; AAI04886.1; -; mRNA. DR EMBL; BC104887; AAI04888.1; -; mRNA. DR EMBL; BC110801; -; NOT_ANNOTATED_CDS; mRNA. DR CCDS; CCDS33886.1; -. [Q5SGD2-1] DR CCDS; CCDS82868.1; -. [Q5SGD2-3] DR CCDS; CCDS82869.1; -. [Q5SGD2-2] DR RefSeq; NP_001304840.1; NM_001317911.1. [Q5SGD2-3] DR RefSeq; NP_001304841.1; NM_001317912.1. [Q5SGD2-2] DR RefSeq; NP_640338.2; NM_139245.3. [Q5SGD2-1] DR AlphaFoldDB; Q5SGD2; -. DR SMR; Q5SGD2; -. DR BioGRID; 127400; 25. DR IntAct; Q5SGD2; 5. DR MINT; Q5SGD2; -. DR STRING; 9606.ENSP00000417659; -. DR DEPOD; PPM1L; -. DR GlyGen; Q5SGD2; 1 site. DR iPTMnet; Q5SGD2; -. DR PhosphoSitePlus; Q5SGD2; -. DR BioMuta; PPM1L; -. DR DMDM; 74743437; -. DR EPD; Q5SGD2; -. DR jPOST; Q5SGD2; -. DR MassIVE; Q5SGD2; -. DR MaxQB; Q5SGD2; -. DR PaxDb; 9606-ENSP00000417659; -. DR PeptideAtlas; Q5SGD2; -. DR ProteomicsDB; 63756; -. [Q5SGD2-1] DR ProteomicsDB; 63757; -. [Q5SGD2-2] DR ProteomicsDB; 63758; -. [Q5SGD2-3] DR ProteomicsDB; 63759; -. [Q5SGD2-4] DR Pumba; Q5SGD2; -. DR TopDownProteomics; Q5SGD2-1; -. [Q5SGD2-1] DR Antibodypedia; 18529; 168 antibodies from 28 providers. DR DNASU; 151742; -. DR Ensembl; ENST00000295839.9; ENSP00000295839.9; ENSG00000163590.14. [Q5SGD2-3] DR Ensembl; ENST00000464260.5; ENSP00000420746.1; ENSG00000163590.14. [Q5SGD2-2] DR Ensembl; ENST00000497343.5; ENSP00000420354.1; ENSG00000163590.14. [Q5SGD2-4] DR Ensembl; ENST00000498165.6; ENSP00000417659.1; ENSG00000163590.14. [Q5SGD2-1] DR GeneID; 151742; -. DR KEGG; hsa:151742; -. DR MANE-Select; ENST00000498165.6; ENSP00000417659.1; NM_139245.4; NP_640338.2. DR UCSC; uc003fds.4; human. [Q5SGD2-1] DR AGR; HGNC:16381; -. DR CTD; 151742; -. DR DisGeNET; 151742; -. DR GeneCards; PPM1L; -. DR HGNC; HGNC:16381; PPM1L. DR HPA; ENSG00000163590; Low tissue specificity. DR MIM; 611931; gene. DR neXtProt; NX_Q5SGD2; -. DR OpenTargets; ENSG00000163590; -. DR PharmGKB; PA134871016; -. DR VEuPathDB; HostDB:ENSG00000163590; -. DR eggNOG; KOG0698; Eukaryota. DR GeneTree; ENSGT00940000157030; -. DR HOGENOM; CLU_013173_11_1_1; -. DR InParanoid; Q5SGD2; -. DR OMA; IDDQEAC; -. DR OrthoDB; 11028at2759; -. DR PhylomeDB; Q5SGD2; -. DR TreeFam; TF332888; -. DR BRENDA; 3.1.3.16; 2681. DR PathwayCommons; Q5SGD2; -. DR Reactome; R-HSA-1660661; Sphingolipid de novo biosynthesis. DR SignaLink; Q5SGD2; -. DR SIGNOR; Q5SGD2; -. DR BioGRID-ORCS; 151742; 5 hits in 1159 CRISPR screens. DR ChiTaRS; PPM1L; human. DR GenomeRNAi; 151742; -. DR Pharos; Q5SGD2; Tbio. DR PRO; PR:Q5SGD2; -. DR Proteomes; UP000005640; Chromosome 3. DR RNAct; Q5SGD2; Protein. DR Bgee; ENSG00000163590; Expressed in Brodmann (1909) area 23 and 192 other cell types or tissues. DR GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome. DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0017018; F:myosin phosphatase activity; IEA:UniProtKB-EC. DR GO; GO:0004722; F:protein serine/threonine phosphatase activity; TAS:Reactome. DR GO; GO:0000165; P:MAPK cascade; IEA:Ensembl. DR GO; GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome. DR GO; GO:0007178; P:transmembrane receptor protein serine/threonine kinase signaling pathway; IEA:Ensembl. DR CDD; cd00143; PP2Cc; 1. DR Gene3D; 3.60.40.10; PPM-type phosphatase domain; 1. DR InterPro; IPR015655; PP2C. DR InterPro; IPR000222; PP2C_BS. DR InterPro; IPR036457; PPM-type-like_dom_sf. DR InterPro; IPR001932; PPM-type_phosphatase-like_dom. DR PANTHER; PTHR47992; PROTEIN PHOSPHATASE; 1. DR PANTHER; PTHR47992:SF105; PROTEIN PHOSPHATASE 1B; 1. DR Pfam; PF00481; PP2C; 1. DR SMART; SM00331; PP2C_SIG; 1. DR SMART; SM00332; PP2Cc; 1. DR SUPFAM; SSF81606; PP2C-like; 1. DR PROSITE; PS01032; PPM_1; 1. DR PROSITE; PS51746; PPM_2; 1. DR Genevisible; Q5SGD2; HS. PE 1: Evidence at protein level; KW Alternative splicing; Hydrolase; Magnesium; Manganese; Membrane; KW Metal-binding; Protein phosphatase; Reference proteome; Transmembrane; KW Transmembrane helix. FT CHAIN 1..360 FT /note="Protein phosphatase 1L" FT /id="PRO_0000057754" FT TOPO_DOM 1..25 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 26..42 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 43..360 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT DOMAIN 92..351 FT /note="PPM-type phosphatase" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01082" FT BINDING 128 FT /ligand="Mn(2+)" FT /ligand_id="ChEBI:CHEBI:29035" FT /ligand_label="1" FT /evidence="ECO:0000250" FT BINDING 128 FT /ligand="Mn(2+)" FT /ligand_id="ChEBI:CHEBI:29035" FT /ligand_label="2" FT /evidence="ECO:0000250" FT BINDING 129 FT /ligand="Mn(2+)" FT /ligand_id="ChEBI:CHEBI:29035" FT /ligand_label="1" FT /evidence="ECO:0000250" FT BINDING 302 FT /ligand="Mn(2+)" FT /ligand_id="ChEBI:CHEBI:29035" FT /ligand_label="2" FT /evidence="ECO:0000250" FT BINDING 342 FT /ligand="Mn(2+)" FT /ligand_id="ChEBI:CHEBI:29035" FT /ligand_label="2" FT /evidence="ECO:0000250" FT VAR_SEQ 1..179 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_016927" FT VAR_SEQ 1..127 FT /note="Missing (in isoform 3)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_037552" FT VAR_SEQ 128..133 FT /note="DGHGGE -> MPAFST (in isoform 3)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_037553" FT VAR_SEQ 192..194 FT /note="GTT -> VTF (in isoform 4)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_037554" FT VAR_SEQ 195..360 FT /note="Missing (in isoform 4)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_037555" FT VARIANT 262 FT /note="A -> S (in dbSNP:rs13326359)" FT /id="VAR_050622" SQ SEQUENCE 360 AA; 41053 MW; 08212E7BA32AFE2B CRC64; MIEDTMTLLS LLGRIMRYFL LRPETLFLLC ISLALWSYFF HTDEVKTIVK SSRDAVKMVK GKVAEIMQND RLGGLDVLEA EFSKTWEFKN HNVAVYSIQG RRDHMEDRFE VLTDLANKTH PSIFGIFDGH GGETAAEYVK SRLPEALKQH LQDYEKDKEN SVLSYQTILE QQILSIDREM LEKLTVSYDE AGTTCLIALL SDKDLTVANV GDSRGVLCDK DGNAIPLSHD HKPYQLKERK RIKRAGGFIS FNGSWRVQGI LAMSRSLGDY PLKNLNVVIP DPDILTFDLD KLQPEFMILA SDGLWDAFSN EEAVRFIKER LDEPHFGAKS IVLQSFYRGC PDNITVMVVK FRNSSKTEEQ //